- Home
- ADVB
as 11-05-2025 4:00pm EST
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | RENO |
| Market Cap: | 10.4M | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.34 - $4.10 | Next Earning Date: | 10-27-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Advanced Biomed Inc. Common Stock News
ADVB Breaking Stock News: Dive into ADVB Ticker-Specific Updates for Smart Investing
MT Newswires
8 months ago
Advanced Biomed Closes $6.6 Million IPO
GlobeNewswire
8 months ago
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
GlobeNewswire
8 months ago
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
Compare ADVB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADVB Advanced Biomed Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.